SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹34 Cr | ₹26 Cr | ₹15 Cr | ₹12 Cr | ₹5.89 Cr |
What is the latest Sundry Debtors ratio of SOTAC PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹34 Cr |
| Mar2024 | ₹26 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹5.89 Cr |
How is Sundry Debtors of SOTAC PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹34 Cr | 29.76 | |
| Mar2024 | ₹26 Cr | 78.33 | |
| Mar2023 | ₹15 Cr | 20.31 | |
| Mar2022 | ₹12 Cr | 108.21 | |
| Mar2021 | ₹5.89 Cr | - | |
Compare Sundry Debtors of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹105.6 Cr | -5.8% | -11.1% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.8% |
-11.1% |
-15.3% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses